Filing Details
- Accession Number:
- 0001209191-17-045120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-13 19:46:45
- Reporting Period:
- 2017-07-11
- Filing Date:
- 2017-07-13
- Accepted Time:
- 2017-07-13 19:46:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422997 | Petrus Bekker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-11 | 6,124 | $6.30 | 65,963 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-11 | 6,124 | $9.30 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-11 | 23,876 | $6.90 | 83,715 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-11 | 23,876 | $9.90 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-12 | 10,000 | $6.00 | 69,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-12 | 10,000 | $10.00 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-12 | 1,250 | $6.30 | 61,089 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-12 | 1,250 | $10.00 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-12 | 9,253 | $6.90 | 69,092 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-12 | 9,253 | $9.92 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-12 | 6,997 | $7.10 | 66,836 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-12 | 6,997 | $10.00 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-12 | 2,500 | $8.19 | 62,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-12 | 2,500 | $10.00 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-13 | 3,888 | $7.10 | 63,727 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-13 | 3,888 | $10.28 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-13 | 12,125 | $8.19 | 71,964 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-13 | 12,125 | $10.19 | 59,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-11 | 6,124 | $0.00 | 6,124 | $6.30 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-11 | 23,876 | $0.00 | 23,876 | $6.90 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-12 | 10,000 | $0.00 | 10,000 | $6.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-12 | 1,250 | $0.00 | 1,250 | $6.30 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-12 | 9,253 | $0.00 | 9,253 | $6.90 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-12 | 6,997 | $0.00 | 6,997 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-12 | 2,500 | $0.00 | 2,500 | $8.19 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-13 | 3,888 | $0.00 | 3,888 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-13 | 12,125 | $0.00 | 12,125 | $8.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,750 | 2020-08-10 | No | 4 | M | Direct | |
| 13,345 | 2021-08-04 | No | 4 | M | Direct | |
| 0 | 2019-02-17 | No | 4 | M | Direct | |
| 2,500 | 2020-08-10 | No | 4 | M | Direct | |
| 4,092 | 2021-08-04 | No | 4 | M | Direct | |
| 135,503 | 2024-02-19 | No | 4 | M | Direct | |
| 191,500 | 2025-02-23 | No | 4 | M | Direct | |
| 131,615 | 2024-02-19 | No | 4 | M | Direct | |
| 179,375 | 2025-02-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $9.90 to $10.00 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $10.00 to $10.37 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- As of July 11, 2017, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
